Cooley
Christophe Beauduin
- Deals
- 3
- Latest
- Apr 2026
- Most deals in
- Biotech
Firm
- Cooley Law firm · 2026 · 3 deals
Often works with
- Div Gupta 2 deals together
- Rowook Park 2 deals together
- Ryan Sansom 2 deals together
- Courtney Thorne 1 deal together
- Rita Sobral 1 deal together
- Kevin Cooper 1 deal together
- Peter Adams 1 deal together
- Trevor Bossi 1 deal together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Apr 2026 | CrossBridge Bio | – | Eli Lilly and Company | Acquisition | Legal adviser to CrossBridge Bio (target) | Announced | 300.0 | Biotech+2 | Eli Lilly and Company acquisition of CrossBridge Bio |
| Feb 2026 | 35Pharma | – | GSK | Acquisition | Legal adviser to 35Pharma (target) | Announced | 950.0 | Biotech+1 | GSK acquisition of 35Pharma |
| Jan 2026 | Repare Therapeutics | – | XenoTherapeutics | Acquisition | Legal adviser to Repare Therapeutics (target) | Completed | – | Biotech+1 | XenoTherapeutics acquisition of Repare Therapeutics |
Deals where Christophe Beauduin is named on the firm's deal team, by the firm or the press.